Skip to main content

Articles

1215 result(s) for 'cancer' within Journal of Ovarian Research

Page 2 of 25

  1. Accumulating evidence has shown that different immunotherapies for ovarian cancer might overcome barriers to resistance to standard ... study investigated the use of vaccine of ovarian cancer stem cells (CSCs) to...

    Authors: Di Wu, Jing Wang, Yunlang Cai, Mulan Ren, Yuxia Zhang, Fangfang Shi, Fengshu Zhao, Xiangfeng He, Meng Pan, Chunguang Yan and Jun Dou
    Citation: Journal of Ovarian Research 2015 8:68
  2. To determine whether magnetic resonance (MR) imaging features combined with apparent diffusion coefficient (ADC)...values could be used as a tool for categorizing ovarian epithelial cancer (OEC) and predicting su...

    Authors: Guofu Zhang, Weigen Yao, Taotao Sun, Xuefen Liu, Peng Zhang, Jun Jin, Yu Bai, Keqin Hua and He Zhang
    Citation: Journal of Ovarian Research 2019 12:59
  3. This study aimed to explore the effects of activating GABAB1 receptor by baclofen on proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) of ovarian cancer cells.

    Authors: Jun Gao, Yao Gao, Shixin Lin, Xia Zou, Yukai Zhu, Xintong Chen, Hong Wan and Hong Zhu
    Citation: Journal of Ovarian Research 2020 13:126
  4. Our previous studies showed the expression of herpes virus entry mediator (HVEM) is high in ovarian cancer samples and correlated to the patient clinic ... explored the role of HVEM in hypoxic ovarian cancer cell...

    Authors: Liyan Duan, Jie Tao, Xiaoqian Yang, Lei Ye, Yueqian Wu, Qizhi He, Yingchun Duan, Li Chen and Jianlong Zhu
    Citation: Journal of Ovarian Research 2020 13:40
  5. Paclitaxel dose-dense regimen has been controversial in clinical trials in recent years. This systematic review and meta-analysis tried to evaluate the efficacy and safety of paclitaxel dose-dense chemotherapy in...

    Authors: Wenjian Gong, Ruidi Yu, Canhui Cao, Yong Fang, Xuejiao Zhao and Qinglei Gao
    Citation: Journal of Ovarian Research 2023 16:136
  6. Vitamin D deficiency and vitamin D receptor (VDR) gene polymorphism, FokI..., is reported to increase the risk of many cancers. Role of vitamin D and its receptor polymorphisms in ovarian cancer has not been clea...

    Authors: Sudhesna Mohapatra, Alpana Saxena, Gauri Gandhi, Bidhan Chandra Koner and Prakash Chandra Ray
    Citation: Journal of Ovarian Research 2013 6:37
  7. Products of the SOX gene family play important roles in the life process. One of the members, SOX7, is associated with the development of a variety of cancers as a tumor suppression factor, but its relevance with...

    Authors: Huidi Liu, Zi-Qiao Yan, Bailiang Li, Si-Yuan Yin, Qiang Sun, Jun-Jie Kou, Dan Ye, Kelsey Ferns, Hong-Yu Liu and Shu-Lin Liu
    Citation: Journal of Ovarian Research 2014 7:87
  8. Epithelial ovarian cancer (EOC) is highly lethal gynecological cancer. Forkhead Box Protein C2 (FOXC2) promotes ... between the polymorphism of FOXC2 and epithelial ovarian cancer susceptibility in Chinese Han po...

    Authors: Zhijiao Zhou, Xiang Ou, Qiong Zou, Ling Chu, Xiyun Quan, Yong Chen and Yang Liu
    Citation: Journal of Ovarian Research 2020 13:34
  9. The global gene regulator Special AT-rich sequence-binding protein1 (SATB1) has been reported to reprogramme tumour cells into a more malignant phenotype and associate with poor clinical outcome in several cancer

    Authors: Björn Nodin, Charlotta Hedner, Mathias Uhlén and Karin Jirström
    Citation: Journal of Ovarian Research 2012 5:24
  10. Lymphovascular space invasion (LVSI) is the first step of hematogenous metastasis. Exploration of the differential miRNA expression profiles between LVSI-positive and LVSI-negative ovarian cancer tissues may help...

    Authors: Jun Li, Huiran Yue, Wenzhi Li, Guohua Zhu, Tingting Zhu, Ruifang Chen and Xin Lu
    Citation: Journal of Ovarian Research 2021 14:166
  11. LAMA3 is a widely studied methylated gene in multiple tumors, but the relationship between chemotherapy resistance in ovarian cancer is unclear. In this study, LAMA3 ... predict the chemotherapy resistance and pr...

    Authors: Li-yuan Feng, Yong-zhi Huang, Wei Zhang and Li Li
    Citation: Journal of Ovarian Research 2021 14:67
  12. RNA methylation can reverse the methylation modification at the RNA level, which is an extremely important epigenetic modification. The function and mechanism of YTHDF2, as a reader of m6A modification, in epithe...

    Authors: Jie Li, Lei Wu, Meili Pei and Yun Zhang
    Citation: Journal of Ovarian Research 2020 13:111
  13. Malnutrition is a significant problem in patients with ovarian cancer. The goal of this study was to ... Global Assessment (SGA) in patients with ovarian cancer treated in an integrative cancer treatment setting.

    Authors: Digant Gupta, Carolyn A Lammersfeld, Pankaj G Vashi, Sadie L Dahlk and Christopher G Lis
    Citation: Journal of Ovarian Research 2008 1:5
  14. Long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) were reported to be aberrantly expressed and related to the pathogenesis of ovarian cancer. However, the role and regulatory mechanism of MSC-AS1 in ovarian cancer

    Authors: Yinling Zhao, Donglan Yuan, Dandan Zhu, Tianhui Xu, Aihua Huang, Li Jiang, Chiwen Liu, Hua Qian and Xinhua Bu
    Citation: Journal of Ovarian Research 2021 14:109
  15. Platinum-resistance (PR) continues to be a major problem in the management of epithelial ovarian cancer (EOC). Response to various chemotherapeutic agents ... the effect of chemotherapy in prostate and pancreatic...

    Authors: Leigh A Solomon, Shadan Ali, Sanjeev Banerjee, Adnan R Munkarah, Robert T Morris and Fazlul H Sarkar
    Citation: Journal of Ovarian Research 2008 1:9
  16. Ovarian cancer is the seventh most common cancer in women and the second most reason of gynecologic cancer-related death. Growing evidence showed that exosomal ... a crucial role in the progression of ovarian cancer

    Authors: Jun Xiong, Xiaoju He, Yuanyuan Xu, Wei Zhang and Fen Fu
    Citation: Journal of Ovarian Research 2021 14:74
  17. China and the rest of the world are experiencing an outbreak of the 2019 novel coronavirus disease (COVID-19). Patients with cancer are more susceptible to viral infection and ... need for chemotherapy is most li...

    Authors: Zhilan Chen, Chun Zhang, Jiu Yin, Xin Xin, Hemei Li, Yapei Wang, Benjamin K. Tsang and Qinghua Zhang
    Citation: Journal of Ovarian Research 2021 14:35
  18. High-grade serous ovarian cancers are a distinct histological subtype of ovarian cancer often characterised by a dysfunctional BRCA/Fanconi...BRCA1 and BRCA2...genes and occur predominantly in high-grade serous cancer

    Authors: Thomas Mikeska, Kathryn Alsop, Gillian Mitchell, David DL Bowtell and Alexander Dobrovic
    Citation: Journal of Ovarian Research 2013 6:26
  19. Serum CA125 is routinely used in the follow up of ovarian cancer. The objective of the present study was ... usefulness of CA125 in the detection of ovarian cancer recurrence.

    Authors: Elizabeth Varughese, Srinivas Kondalsamy-Chennakesavan and Andreas Obermair
    Citation: Journal of Ovarian Research 2012 5:11
  20. In the search for unique ovarian cancer biomarkers, ovarian specific cDNA microarray analysis identified ... checkpoint protein, as over-expressed in ovarian cancer. The aim of this study was to...

    Authors: Jennifer L Young, E Colin Koon, Joseph Kwong, William R Welch, Michael G Muto, Ross S Berkowitz and Samuel C Mok
    Citation: Journal of Ovarian Research 2011 4:6
  21. Ovarian cancer (OC) can occur at different ages ... risk of cardiovascular mortality in patients with ovarian cancer, we included influencing factors including age, ... on cardiovascular death events in patients ...

    Authors: Ze-Lin Hu, Ying-Xue Yuan, Meng-Yi Xia, Ying Li, Ying Yang, Sheng-Nan Wang, Xuan-Zhu Meng, Mo-Ying Sun and Ning Wang
    Citation: Journal of Ovarian Research 2024 17:88
  22. Epithelial ovarian carcinoma (EOC) is a genetically heterogeneous disease that is partly driven by molecular defects in mismatch repair (MMR) or homology-directed DNA repair (HDR). Ribonuclease H2 serves to remov...

    Authors: Rahel Polaczek, Peter Schürmann, Lisa-Marie Speith, Robert Geffers, Matthias Dürst, Peter Hillemanns, Tjoung-Won Park-Simon, Clemens Liebrich and Thilo Dörk
    Citation: Journal of Ovarian Research 2020 13:146
  23. Niraparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, is approved for first/second-line maintenance treatment of ovarian cancer patients with complete or partial response to...

    Authors: Jing Ni, Xianzhong Cheng, Qian Zhao, Zhiqin Dai, Xia Xu, Wenwen Guo, Hongyuan Gu, Rui Zhou, Yan Wang and Xiaoxiang Chen
    Citation: Journal of Ovarian Research 2021 14:68
  24. Wnt-inducible signaling pathway protein 2 (WISP2) is a wnt1-induced signaling pathway protein 2. Although studies indicate that WISP2 may promote the development of various tumors, its role in ovarian cancer rema...

    Authors: Zi-Qing Shi, Zi-Yan Chen, Yao Han, Heng-Yan Zhu, Meng-Dan Lyu, Han Zhang, Yi Zhang, Liu-Qing Yang and Wei-Wei Pan
    Citation: Journal of Ovarian Research 2020 13:85
  25. ...circular RNAs (circRNAs) have been reported to be essential regulators of multiple malignant cancers. However, the functions of circRNAs in ovarian cancer need to be further explored. The aim ... explore the r...

    Authors: Qin Xu, Bo Deng, Manlin Li, Yang Chen and Li Zhuan
    Citation: Journal of Ovarian Research 2020 13:81
  26. Recent studies have suggested that estrogen (E2) plays an important role in epithelial ovarian cancer (EOC). However, the mechanism of E2 in ovarian cancers is unclear. The purpose of this study ... to investigat...

    Authors: Shengnan Li, Kuo Jiang, Jia Li, Xiaohua Hao, Wenguang Chu, Ceng Luo, Yuanyuan Zhu, Rougang Xie and Biliang Chen
    Citation: Journal of Ovarian Research 2020 13:20
  27. Epithelial ovarian cancer (EOC) has the worst prognosis in ... Failure of traditional treatment in recurrent epithelial ovarian cancer remains a challenge for clinicians. On the...125I brachytherapy has been acce...

    Authors: Lin Xiao, Junying Tang, Wenbo Li, Xuexun Xu and Hao Zhang
    Citation: Journal of Ovarian Research 2020 13:141
  28. Increasing researches have demonstrated the critical functions of circular RNAs (circRNAs) in the progression of malignant tumors, including ovarian cancer. In this study, we aim to ... the role of hsa_circ_00786...

    Authors: Nan Zhang, Yue Jin, Qiubo Hu, Shanshan Cheng, Chao Wang, Zhiyou Yang and Yu Wang
    Citation: Journal of Ovarian Research 2020 13:64
  29. Multifaceted functions of the so-called “oncogene” Wip1 have been reported in a previous study, while its actual role remains to be explored in serous ovarian cancer (SOC). In this study, by...

    Authors: Sheng Yin, Lina Yang, Yiyan Zheng and Rongyu Zang
    Citation: Journal of Ovarian Research 2022 15:56

    The Correction to this article has been published in Journal of Ovarian Research 2022 15:82

  30. The intra-abdominal cavity, surrounded by adipocytes, is the main metastatic site of epithelial ovarian, fallopian tube, and peritoneal cancer. Epidemiological and molecular studies have demonstrated a link betwe...

    Authors: Sooji Ham, Jin Hwa Choi, Soo Gui Shin and Eun-Ju Lee
    Citation: Journal of Ovarian Research 2023 16:19

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.118 - SNIP (Source Normalized Impact per Paper)
    0.965 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    1,114,260 downloads
    475 Altmetric mentions

Editor News

New Content ItemEditor-in-Chief Dr Ben Tsang has been recognised by the Canadian Parliament for significant contributions to science. Please join us in celebrating this amazing achievement.

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.